RBOT, RBOTW · CIK 0001812173 · operating
# Vicarious Surgical Inc.
Vicarious Surgical develops and commercializes single-port surgical robotic systems for minimally invasive procedures in the United States. The company's core product, the Vicarious Surgical System, enables surgeons to perform complex abdominal and other invasive surgeries through a single incision. The platform uses a virtual reality interface that creates a three-dimensional view of the surgical field, positioning the surgeon's perspective inside the patient during the procedure.
Founded in 2014 and headquartered in Waltham, Massachusetts, the company operates with approximately 121 full-time employees. Vicarious Surgical is publicly traded on the New York Stock Exchange under the ticker symbol RBOT. The company is incorporated in Delaware. As of the most recent reporting period, the company had a market capitalization of approximately zero, reflecting recent significant stock price declines from its public market debut.
The company generates revenue primarily through the sale and deployment of its surgical robotic systems. Revenue streams include equipment sales and associated service contracts, though specific segment breakdowns and financial performance details are not disclosed in the available summary data.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | — | — | |
| 2023 | $-0.49 | $-0.49 | -1325.0% | |
| 2022 | $0.04 | $0.04 | +111.1% | |
| 2021 | $-0.36 | $-0.36 | — | |
| 2020 | — | — | — |